Glucose-induced effects and joker function of glucose: Endocrine or genotoxic prevalence?

Hormone and Metabolic Research

Volumn 38, Issue 10, 2006, Pages 650-655

  Berstein, Lev M ^a   Vasilyev, D A ^a   Poroshina, T E ^a   Kovalenko, I G ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

Duality of effects; Genotoxicity; Glucose; Insulin; ROS (reactive oxygen species)

Indexed keywords

GLUCOSE; LEPTIN; LIPID; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENDOCRINE FUNCTION; FEMALE; GENOTOXICITY; GENOTYPE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PROTEINS; ENDOCRINE SYSTEM; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; LEPTIN; LIPIDS; MALE; MALONDIALDEHYDE; MIDDLE AGED; POSTPRANDIAL PERIOD; PREVALENCE; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33751061977     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-954589     Document Type: Article

References (36)

1. Zimmet P. The burden of type 2 diabetes: are we doing enough? Diabetes Metab 2003; 29 (4 Pt 2): S9-S18
2. Dilman VM. Development, ageing and disease. A new rationale for an intervention strategy. Chur (Switzerland): Harwood Acad Publ 1994; 387
3. Reaven G. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995; 75: 473-486
4. Schinner S, Scherbaum WA, Bornstein SR, Barthel A. Molecular mechanisms of insulin resistance. Diabet Med 2005; 22: 674-682
5. United Nations World Population Aging: 1950-2050. UN Publications, DESA, Population Division. NY: UN, 2001 [http:/www.un.org/esa/population/publications/ worldageing19502050]
6. Brand-Miller JC. Glycemic load and chronic disease. Nutr Rev 2003; 61 (5 Pt 2): S49-S55
7. Haffner SM. The importance of hyperglycemia in nonfasting state to the development of cardiovascular disease. Endocr Rev 1998; 19: 583-592
8. Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE. Dietary carbohydrates and breast cancer risk: a prospective study of the roles of overall glycemic index and glycemic load. Int J Cancer 2005; 114: 653-658
9. Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D, Tajima N, Tuomilehto J. Postprandial glucose regulation and diabetic complications. Arch Intern Med 2004; 164: 2090-2095
10. Bouche C, Serdy S, Kahn CR, Goldfine AB. The cellular fate of glucose and its relevance in type 2 diabetes. Endocr Rev 2004; 25: 807-830
11. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. β-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocr Metabol 2005; 90: 493-500
12. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet 1996; 347: 444-445
13. Ceriello A, Quatraro A, Giugliano D. Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress. Diabetologia 1993; 36: 265-266
14. Lin Y, Berg AH, Iyengar P, Lam TK, Giacca A, Combs TP, Rajala MW, Du X, Rollman B, Li W, Hawkins M, Barzilai N, Rhodes CJ, Fantus IG, Brownlee M, Scherer PE. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem. 2005; 280: 4617-4626
15. Konukoglu D, Dogan E, Turhan MS, Husrev Hatemi H. Impaired glucose tolerance: its relevance to early endothelial dysfunction. Horm Metab Res. 2003; 35: 607-610
16. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metabol 2000; 85: 2970-2973
17. Berstein LM. The joker function of glucose in the development of main non-communicable human diseases. Vestn Russian Acad Med Sci 2005; N2: 48-51
18. Berstein LM, Tsyrlina EV, Vasilyev DA, Poroshina TE, Kovalenko IG. Phenomenon of the switching of estrogen effects and joker function of glucose: similarities, relation to age-associated pathology, approaches to correction. Ann N Y Acad Sci 2005; 1057: 235-246
19. Dandona P, Thusu K, Hafeez R, Abdel-Rahman E, Chaudhuri A. Effect of hydrocortisone on oxygen free radical generation by mononuclear cells. Metabolism 1998; 47: 788-791
20. Jayshree RS, Ganguli NK, Dubey ML, Mohan K, Mahajan RC. Generation of reactive oxygen species by blood monocytes during acute Plasmodium knowlesi infection in rhesus monkeys. APMIS 1993; 101: 762-766
21. Ledvina M. Estimation of β-lipoproteins in the blood serum with turbidimetric method. Lab Delo 1960; N3: 13-17
22. Okhawa H, Ohishi N, Yagi K. Reaction of lipid peroxides with thiobarbituric acid. J Lipid Res 1978; 19: 1053-1057
23. Levine RL, Garland CN, Oliver CN. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-478
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner R. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419
25. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocrine Rev 2003; 24: 278-301
26. Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V, Peppa M, Rayfield EJ. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA 2002, 99: 15596-15601
27. Droge W. Free radicals in the physiologic control of cell function. Physiol Rev 2002; 82: 47-95
28. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761
29. Dandona P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, Prabhala A, Afzal A, Garg R. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metabol 2001; 86: 355-362
30. Braga PC, Sala MT, Dal Sasso M, Mancini L, Sandrini MC, Annoni G. Influence of age on oxidative burst (chemiluminescence) of polymorphonuclear neutrophil leukocytes. Gerontology 1998; 44: 192-197
31. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S. Insulin inhibits intranuclear factor κB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metabol 2001; 86: 3257-3265
32. Basu R, Breda E, Oberg RL, Powell CC, Dalla Man C, Rizza RA. Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes 2003; 52: 1738-1748
33. Berstein LM. Oncoendocrinology: traditions, present situation and perspectives. St. Petersburg: Nauka Publ, 2004; 343
34. Liehr JG. Dual role of oestrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens. Eur J Cancer Prev 1997;6:3-10
35. Santen RJ. Endocrine-responsive cancer. In: Larsen PR. et al., eds. Williams textbook of endocrinology. Philadelphia. W. B. Saunders Comp, 2003; 1797-1833
36. Andreassi MG, Botto N. DNA damage as a new emerging risk factor in atherosclerosis. Trends Cardiovasc Med 2003; 13: 270-275